05Jun
What We Learned From FDA's Public Hearing On Cannabis
The much-anticipated public hearing last week at the U.S. Food and Drug Administration on cannabis and cannabis-derived compounds drew a wide audience of participants, with strong views on how the FDA should (or should not) regulate the controversial...
By:
Sheppard Mullin Richter & Hampton LLP
Related
Given the ongoing developments with the Coronavirus outbreak, we want to provide you with simple pro...
Read More >
CSG Labor & Employment Alert - The U.S. Department of Labor’s Occupational Safety and Health Admin...
Read More >
The United States Supreme Court will decide three cases in October 2019 to determine if Title VII of...
Read More >
Seyfarth Synopsis: OSHA recently updated its National Emphasis Program on Amputations in Manufacturi...
Read More >
Publicly traded companies need to know whether a director qualifies as "independent" for a variety o...
Read More >
In an effort to prevent persons with criminal records from being automatically ruled out for job vac...
Read More >